Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

Share Price Information for Totally (TLY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.00
Bid: 4.50
Ask: 5.50
Change: 0.00 (0.00%)
Spread: 1.00 (22.222%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.10
TLY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

7 Mar 2017 10:30

RNS Number : 7408Y
Totally PLC
07 March 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Totally Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Seneca Partners Limited

4. Full name of shareholder(s)  (if different from 3.):iv

Share Nominees Limited

WCS Nominees Limited

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

02.03.2017

6. Date on which issuer notified:

07.03.2017

7. Threshold(s) that is/are crossed orreached: vi, vii

15%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary shares of £0.10

2,916,000

2,916,000

3,370,545

3,370,545

15.77%

GB00BYM1JJ00

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,370,545

15.77%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Seneca Partners Limited; 3,370,545 shares; 15.77%

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

The shares referred to in section 9 are held in portfolios managed by Seneca Partners Limited on a discretionary basis for clients under investment management agreements. This disclosure has been calculated based on issue share capital amount 21,377,715.

14. Contact name:

Anthony Lappin

15. Contact telephone number:

01942 271 746

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLOKODBKBKDONK
Date   Source Headline
9th Nov 20207:00 amRNSInterim results
2nd Nov 20207:00 amRNSNotice of Interim Results
14th Oct 20204:03 pmRNSHolding(s) in Company
13th Oct 20205:23 pmRNSReplacement: Holding(s) in Company
13th Oct 20202:09 pmRNSHolding(s) in Company
12th Oct 20207:00 amRNSHolding(s) in Company
2nd Oct 202012:22 pmRNSHolding(s) in Company
8th Sep 20204:30 pmRNSDirector/PDMR Notification
8th Sep 20208:54 amRNSHolding(s) in Company
7th Sep 20203:28 pmRNSResult of AGM
7th Sep 20207:00 amRNSAGM Statement and Trading Update
17th Aug 20207:00 amRNSContract Extensions and Pilot Worth c.£7.5 million
27th Jul 20207:00 amRNSHolding(s) in Company
27th Jul 20207:00 amRNSHolding(s) in Company
24th Jul 20203:02 pmRNSPosting of Annual Report and Accounts
24th Jul 202010:33 amRNSDirector/PDMR Shareholding
24th Jul 20209:21 amRNSHolding(s) in Company
23rd Jul 20204:27 pmRNSHolding(s) in Company
23rd Jul 202012:52 pmRNSDirector/PDMR Shareholding
22nd Jul 20204:09 pmRNSHolding(s) in Company
14th Jul 20206:09 pmRNSHolding(s) in Company
9th Jul 20204:07 pmRNSHolding(s) in Company
8th Jul 20207:00 amRNSInvestor Presentation - Preliminary Results
7th Jul 20207:00 amRNSPreliminary results
23rd Jun 20207:00 amRNSDirectorate Change
1st Jun 202010:20 amRNSDirector/PDMR notification
20th May 20204:41 pmRNSSecond Price Monitoring Extn
20th May 20204:36 pmRNSPrice Monitoring Extension
14th May 20207:00 amRNSVocare awarded significant contract extensions
13th May 20202:10 pmRNSHolding(s) in Company
12th May 202012:26 pmRNSHolding(s) in Company
6th May 20204:40 pmRNSSecond Price Monitoring Extn
6th May 20204:35 pmRNSPrice Monitoring Extension
6th May 20202:06 pmRNSSecond Price Monitoring Extn
6th May 20202:00 pmRNSPrice Monitoring Extension
5th May 20205:47 pmRNSHolding(s) in Company
5th May 20202:38 pmRNSProposed purchase of Ordinary Shares
4th May 20202:44 pmRNSHolding(s) in Company
23rd Apr 20201:21 pmRNSHolding(s) in Company
20th Apr 20207:00 amRNSTrading Update
27th Mar 202011:05 amRNSSecond Price Monitoring Extn
27th Mar 202011:00 amRNSPrice Monitoring Extension
27th Mar 20207:00 amRNSUpdate on COVID-19
3rd Mar 20202:06 pmRNSSecond Price Monitoring Extn
3rd Mar 20202:00 pmRNSPrice Monitoring Extension
7th Feb 20202:05 pmRNSSecond Price Monitoring Extn
7th Feb 20202:00 pmRNSPrice Monitoring Extension
7th Feb 202010:04 amRNSAbout Health: Key new £8.4m contract in Manchester
22nd Jan 20207:00 amRNSDividend Declaration
6th Jan 20206:29 pmRNSGrant of Options under SAYE Option Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.